Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma
- 6 January 2009
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 123 (2) , 411-416
- https://doi.org/10.1016/j.jaci.2008.11.016
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute
This publication has 27 references indexed in Scilit:
- Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007Journal of Allergy and Clinical Immunology, 2007
- PrefaceJournal of Allergy and Clinical Immunology, 2007
- Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukastPharmacogenetics and Genomics, 2007
- Severity, control, and responsiveness in asthmaJournal of Allergy and Clinical Immunology, 2006
- Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthmaJournal of Allergy and Clinical Immunology, 2006
- Characterization of within-subject responses to fluticasone and montelukast in childhood asthmaJournal of Allergy and Clinical Immunology, 2005
- Parental asthma as a risk factor for the development of early skin test sensitization in childrenJournal of Allergy and Clinical Immunology, 2004
- Response of preschool children with asthma symptoms to fluticasone propionateJournal of Allergy and Clinical Immunology, 2001
- Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstrictionJournal of Allergy and Clinical Immunology, 1999
- Induced sputum and response to glucocorticoids☆☆☆★Journal of Allergy and Clinical Immunology, 1998